Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The tryptophan catabolite or kynurenine pathway in schizophrenia: meta-analysis reveals dissociations between central, serum, and plasma compartments
Abbas F. Almulla, Asara Vasupanrajit, Chavit Tunvirachaisakul, et al.
Molecular Psychiatry (2022) Vol. 27, Iss. 9, pp. 3679-3691
Open Access | Times Cited: 63

Showing 1-25 of 63 citing articles:

Probiotic, prebiotic, synbiotic and fermented food supplementation in psychiatric disorders: A systematic review of clinical trials
Carlos Ribera, Joan Vicent Sánchez‐Ortí, Gerard Clarke, et al.
Neuroscience & Biobehavioral Reviews (2024) Vol. 158, pp. 105561-105561
Open Access | Times Cited: 21
Tryptophan Metabolism in Central Nervous System Diseases: Pathophysiology and Potential Therapeutic Strategies
Yinrou Huang, Mengke Zhao, Xuemei Chen, et al.
Aging and Disease (2022) Vol. 14, Iss. 3, pp. 858-858
Open Access | Times Cited: 62
The tryptophan catabolite or kynurenine pathway in COVID-19 and critical COVID-19: a systematic review and meta-analysis
Abbas F. Almulla, Thitiporn Supasitthumrong, Chavit Tunvirachaisakul, et al.
BMC Infectious Diseases (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 60
Tryptophan catabolites, inflammation, and insulin resistance as determinants of chronic fatigue syndrome and affective symptoms in long COVID
Hussein Kadhem Al‐Hakeim, Anwar Khairi Abed, Shatha Rouf Moustafa, et al.
Frontiers in Molecular Neuroscience (2023) Vol. 16
Open Access | Times Cited: 35
Reverse cholesterol transport and lipid peroxidation biomarkers in major depression and bipolar disorder: A systematic review and meta-analysis
Abbas F. Almulla, Yanin Thipakorn, Ali Abbas Abo Algon, et al.
Brain Behavior and Immunity (2023) Vol. 113, pp. 374-388
Open Access | Times Cited: 34
Neuroactive Kynurenines as Pharmacological Targets: New Experimental Tools and Exciting Therapeutic Opportunities
Ana Pocivavsek, Robert Schwarcz, Sophie Erhardt
Pharmacological Reviews (2024) Vol. 76, Iss. 6, pp. 978-1008
Closed Access | Times Cited: 8
Identification of Two Flavonoids as New and Safe Inhibitors of Kynurenine Aminotransferase II via Computational and In Vitro Study
Redouane Rebai, Luc Jasmin, Abdennacer Boudah
Pharmaceuticals (2025) Vol. 18, Iss. 1, pp. 76-76
Open Access | Times Cited: 1
Kynurenic Acid and Promotion of Activity-Dependent Synapse Elimination in Schizophrenia
Funda Orhan, Susmita Malwade, Neda Khanlarkhani, et al.
American Journal of Psychiatry (2025) Vol. 182, Iss. 4, pp. 389-400
Closed Access | Times Cited: 1
The tryptophan catabolite or kynurenine pathway in major depressive and bipolar disorder: A systematic review and meta-analysis
Abbas F. Almulla, Yanin Thipakorn, Asara Vasupanrajit, et al.
Brain Behavior & Immunity - Health (2022) Vol. 26, pp. 100537-100537
Open Access | Times Cited: 33
Kynurenine pathway abnormalities are state-specific but not diagnosis-specific in schizophrenia and bipolar disorder
Katrien Skorobogatov, Valérie Autier, Marianne Foiselle, et al.
Brain Behavior & Immunity - Health (2023) Vol. 27, pp. 100584-100584
Open Access | Times Cited: 22
Multiomics Analyses Reveal Microbiome–Gut–Brain Crosstalk Centered on Aberrant Gamma-Aminobutyric Acid and Tryptophan Metabolism in Drug-Naïve Patients with First-Episode Schizophrenia
Zhuo Wang, Xiuxia Yuan, Zijia Zhu, et al.
Schizophrenia Bulletin (2023) Vol. 50, Iss. 1, pp. 187-198
Closed Access | Times Cited: 18
Maternal Inflammation with Elevated Kynurenine Metabolites Is Related to the Risk of Abnormal Brain Development and Behavioral Changes in Autism Spectrum Disorder
Yuki Murakami, Yukio Imamura, Yoshiyuki Kasahara, et al.
Cells (2023) Vol. 12, Iss. 7, pp. 1087-1087
Open Access | Times Cited: 17
Differences in the gut microbiome of young adults with schizophrenia spectrum disorder: using machine learning to distinguish cases from controls
Miranda Stiernborg, Stefanie Prast‐Nielsen, Philippe A. Melas, et al.
Brain Behavior and Immunity (2024) Vol. 117, pp. 298-309
Open Access | Times Cited: 6
The Tryptophan Catabolite or Kynurenine Pathway in Alzheimer’s Disease: A Systematic Review and Meta-Analysis
Abbas F. Almulla, Thitiporn Supasitthumrong, Arisara Amrapala, et al.
Journal of Alzheimer s Disease (2022) Vol. 88, Iss. 4, pp. 1325-1339
Open Access | Times Cited: 23
The kynurenine pathway in treatment-resistant schizophrenia at the crossroads between pathophysiology and pharmacotherapy
Jacopo Sapienza, Giulia Agostoni, Stefano Dall’Acqua, et al.
Schizophrenia Research (2023) Vol. 264, pp. 71-80
Closed Access | Times Cited: 14
The Tryptophan Catabolite or Kynurenine Pathway’s Role in Major Depression
Abbas F. Almulla, Michaël Maes
Current Topics in Medicinal Chemistry (2022) Vol. 22, Iss. 21, pp. 1731-1735
Open Access | Times Cited: 22
The Tryptophan Catabolite or Kynurenine Pathway in a Major Depressive Episode with Melancholia, Psychotic Features and Suicidal Behaviors: A Systematic Review and Meta-Analysis
Abbas F. Almulla, Yanin Thipakorn, Asara Vasupanrajit, et al.
Cells (2022) Vol. 11, Iss. 19, pp. 3112-3112
Open Access | Times Cited: 21
Although serotonin is not a major player in depression, its precursor is
Abbas F. Almulla, Michaël Maes
Molecular Psychiatry (2023) Vol. 28, Iss. 8, pp. 3155-3156
Closed Access | Times Cited: 11
Elevated serum kynurenic acid in individuals with first-episode psychosis and insufficient response to antipsychotics
Alexandros Hatzimanolis, Stefania Foteli, Lida‐Alkisti Xenaki, et al.
Schizophrenia (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 4
Immune activation and immune-associated neurotoxicity in Long-COVID: A systematic review and meta-analysis of 103 studies comprising 58 cytokines/chemokines/growth factors
Abbas F. Almulla, Yanin Thipakorn, Bo Zhou, et al.
Brain Behavior and Immunity (2024) Vol. 122, pp. 75-94
Open Access | Times Cited: 4
Peripheral tryptophan-kynurenine pathway dysfunction in first-episode schizophrenia
Mian Li, Yue Wu, Yan Xu, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Acid-catalyzed preparation of silicon-based imprinted polymers on the surface of SERS sensors for selective detection of L-tryptophan
Xinyi Liu, Huiyan Wei, Meiqi Ju, et al.
Journal of environmental chemical engineering (2025), pp. 115858-115858
Closed Access
Potential role for kynurenine pathway in increased COVID-19 mortality of patients with schizophrenia
Pengli Wang, Zhen-Ying Li, Jie Wang, et al.
Journal of Psychiatric Research (2025) Vol. 183, pp. 289-295
Closed Access
Metabolic Syndrome and Schizophrenia: Adding a Piece to the Interplay Between the Kynurenine Pathway and Inflammation
Jacopo Sapienza, Giulia Agostoni, Federica Repaci, et al.
Metabolites (2025) Vol. 15, Iss. 3, pp. 176-176
Open Access
Importance of the dysregulation of the kynurenine pathway on cognition in schizophrenia: a systematic review of clinical studies
Jacopo Sapienza, Marco Spangaro, Gilles J. Guillemin, et al.
European Archives of Psychiatry and Clinical Neuroscience (2022) Vol. 273, Iss. 6, pp. 1317-1328
Closed Access | Times Cited: 17
Page 1 - Next Page

Scroll to top